Furthermore, hepatic steatosis due to non-alcoholic fatty liver disease (NAFLD) leads to and is often clinically suspected by increased levels of aminotransferases, with levels of alanine aminotransferase (ALT) exceeding those of aspartate aminotransferase (AST). This evidence concerns the gene GPT and fatty liver disease.